MoneyWorks4Me

The sales declined to Rs. 3608.20 millions for the March 2022 quarter as compared to Rs. 4442.10 millions during the corresponding quarter last year.A big loss of -99.62% reported for the quarter ended March 2022 to Rs. 2.20  millions from Rs. 571.50 millions.Operating Profit reported a sharp decline to 176.30 millions from 1093.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3608.20 4442.10 -18.77 12683.40 16168.80 -21.56 12683.40 16168.80 -21.56
Other Income 46.90 98.60 -52.43 187.60 284.10 -33.97 187.60 284.10 -33.97
PBIDT 176.30 1093.70 -83.88 991.10 4137.40 -76.05 991.10 4137.40 -76.05
Interest 214.60 248.60 -13.68 752.70 844.70 -10.89 752.70 844.70 -10.89
PBDT -51.40 845.10 -106.08 203.50 3292.70 -93.82 203.50 3292.70 -93.82
Depreciation 277.40 273.60 1.39 1120.10 1083.10 3.42 1120.10 1083.10 3.42
PBT -328.80 571.50 -157.53 -916.60 2209.60 -141.48 -916.60 2209.60 -141.48
TAX -331.00 0.00 0.00 -331.00 0.00 0.00 -331.00 0.00 0.00
Deferred Tax -331.00 -100.10 230.67 -331.00 -386.40 -14.34 -331.00 -386.40 -14.34
PAT 2.20 571.50 -99.62 -585.60 2209.60 -126.50 -585.60 2209.60 -126.50
Equity 360.00 358.10 0.53 360.00 359.30 0.19 360.00 359.30 0.19
PBIDTM(%) 4.89 24.62 -80.15 7.81 25.59 -69.46 7.81 25.59 -69.46

Solara Active Pharma Share Price

511.05 -7.60 (-1.47%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: